Showing results (241-250 of 3,657) with videos related to

Sort By:
Pageof 366
Breast Cancer Research : BCR|December 21, 2017
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancerHao-Yi Li, Jui-Lin Liang, Yao-Lung Kuo, et al.
Breast Cancer Research : BCR|January 25, 2019
Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancerMarie-Julie Nokin, Justine Bellier, Florence Durieux, et al.
Breast Cancer Research : BCR|January 27, 2019
Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifierYoudinghuan Chen, Yue Wang, Lucas A Salas, et al.
Breast Cancer Research : BCR|January 16, 2019
Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brainMagdalena Kijewska, Carmen Viski, Frances Turrell, et al.
Breast Cancer Research : BCR|January 18, 2019
Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3β activitiesHye Yeon Choi, Gwang-Mo Yang, Ahmed Abdal Dayem, et al.
Breast Cancer Research : BCR|December 21, 2019
NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosisLingfeng Wan, Tao Liu, Zhipeng Hong, et al.
Breast Cancer Research : BCR|December 21, 2019
Immune gene expression profiling reveals heterogeneity in luminal breast tumorsBin Zhu, Lap Ah Tse, Difei Wang, et al.
Breast Cancer Research : BCR|December 13, 2019
Characterization of organoid cultured human breast cancerNadine Goldhammer, Jiyoung Kim, Vera Timmermans-Wielenga, et al.
Breast Cancer Research : BCR|December 13, 2019
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapyBruno Valentin Sinn, Karsten E Weber, Wolfgang Daniel Schmitt, et al.
Breast Cancer Research : BCR|August 24, 2017
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomesElsa Curtit, Xavier Pivot, Julie Henriques, et al.
Pageof 366